General MM

Prof. Noopur S. Raje | 2017 ASCO Annual Meeting | Impact of denosumab (DMB) compared with zoledronic acid (ZA) on renal function in the treatment of myeloma bone disease


2017 ASCO Annual Meeting - 2-6 June, Chicago 
Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF